Assessment of pain and adverse symptoms in cancer patients on admission to a university hospital;Symptomregistrering hos kreftpasienter ved sykehusinnleggelse

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 18, 2005, Pages 2500-2503

  Seland, Mette ^a,d   Kaasa, Stein ^a,b   Klepstad, Pål ^b,c  

^a Institutt for kreftforskning og molekylær medisin   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d TELEMARK HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CANCER PATIENT; FEMALE; HOSPITAL ADMISSION; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; NAUSEA; NURSE; PAIN ASSESSMENT; RATING SCALE; SEDATION; SELF REPORT; SIDE EFFECT; STANDARDIZATION; SYMPTOM; TREATMENT FAILURE; UNIVERSITY HOSPITAL; COMPARATIVE STUDY; HEALTH PERSONNEL ATTITUDE; METHODOLOGY; MIDDLE AGED; NEOPLASM; PAIN; PHYSICIAN; STANDARD;

ADULT; AGED; ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; NURSES; PAIN; PAIN MEASUREMENT; PATIENT ADMISSION; PHYSICIANS;

EID: 26044467159     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Caraceni A. Evaluation and assessment of cancer pain and cancer pain treatment. Acta Anaesthesiol Scand 2001; 45: 1067-75.
2. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 197-210.
3. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-99.
4. Skauge M, Borchrevink PC, Kaasa S. Pasienter med kreftrelaterte og andre kroniske smerter. Prioritering og vurdering. Tidsskr Nor Lægeforen 1996; 116: 473-7.
5. Klepstad P, Loge JH, Borchrevink PC et al. The Norwegian Brief Pain Inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 2002; 24: 517-25.
6. Melsom H, Wist E. Terminalomsorg til kreft-pasienter. Tidsskr Nor Lægeforen 2001; 121: 2590-2.
7. Klepstad P, Dale O, Kaasa S et al. Influences on serum concentrations of morphine, M6G and M3G during routine clinical monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiol Scand 2003; 47: 725-31.
8. Karnofsky DA, Abelmann WH, Craver LF et al. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-56.
9. Serlin RC, Mendoza TR, Nakamura Y et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61: 277-84.
10. Bruera E, Kuehn N, Miller MJ et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991; 7: 6-9.